ArticleScientific reports2020

Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases.

Shrishti Saxena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.